Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
---|
05/22/1990 | US4927822 Hypotensive |
05/22/1990 | US4927814 Bone disorders |
05/22/1990 | US4927807 Renin inhibiting amides |
05/22/1990 | CA1269497A1 Amino acid ester and amide renin inhibitors |
05/22/1990 | CA1269496A1 Mercaptocycloalkylcarbonyl and mercaptoarylcarbonyl dipeptides |
05/22/1990 | CA1269371A1 Polycyclic aromatic derivatives, and their use in cosmetics |
05/22/1990 | CA1269367A1 Sialosylcerebrosides and a preparation method thereof |
05/21/1990 | CA2003537A1 Inhibitors for glycosaminosyl transferase v |
05/21/1990 | CA2003395A1 Anti-atherosclerotic diaryl compounds |
05/21/1990 | CA2003385A1 A method for enhancing the lowering of plasma cholesterol levels |
05/18/1990 | CA2003091A1 Substituted oxadiaminobutanes |
05/18/1990 | CA2002965A1 Conjugate of prostaglandin and polysaccharide |
05/17/1990 | WO1990005185A1 Modified human growth hormone |
05/17/1990 | WO1990005147A1 Natural killer stimulatory factor |
05/17/1990 | WO1990005130A1 2-aminocarboxylic acid derivatives, their manufacture and use as drugs |
05/17/1990 | WO1990004973A1 Treatment of myelosuppression associated with acquired immune deficiency |
05/17/1990 | WO1990004917A1 Heterocyclic peptide renin inhibitors |
05/17/1990 | WO1990001321A3 Method for treating and preventing loss of bone mass |
05/17/1990 | CA2001159A1 7-oxadicycloheptane imino interphenyleneoxy substituted prostaglandin analogs useful in the treatment of thrombotic and vasospastic disease |
05/17/1990 | CA2001028A1 7-oxabicycloheptane imino interphenylene substituted prostaglandin analogs useful in the treatment of thrombotic disease |
05/16/1990 | EP0368758A2 Zinc cysteate, its preparation and its pharmaceutical and cosmetic uses |
05/16/1990 | EP0368719A2 Novel analogs of peptidase substrates |
05/16/1990 | EP0368464A1 Thiopene-2 carboxamide derivatives and their pharmaceutical use |
05/16/1990 | EP0368388A2 3-Piperidinyl-1,2-benzisoxazoles |
05/16/1990 | EP0368223A2 Use of ethylene diamine tetraacetic acid as inhibitor of calcium/calmoduline-dependent protein kinase II or protein kinase C |
05/16/1990 | EP0368175A1 3S,7S-3-(Morpholinocarbonyl)-5-(2-chlorphenyl)-7,10-dimethyl-3,4-dihydro-2H,7H-cyclopenta[4,5]thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine. |
05/16/1990 | EP0305297B1 Derivatives of aza-z-bicyclooctane-caboxylicacid-3, processes for their preparation and pharmaceutical compositions containing them |
05/16/1990 | CN1042145A Novel quinolyloxazole-2-ones useful as proteinkinase c inhibitors |
05/16/1990 | CN1042075A Medicines for transcortical application containing steroidhormonen |
05/15/1990 | US4925932 Preparation of double sulfate salt of desoxyfructosyl serotonin and creatinine |
05/15/1990 | US4925871 Antiulcer, capillary permeability, wound healing |
05/15/1990 | US4925870 Antiulcer and wound healing agents |
05/15/1990 | US4925869 Reactivating enzyme acetylcholinesterase inhibited by lethal dose of soman |
05/15/1990 | US4925861 Leukotriene antagonists, phospholipase inhibitors |
05/15/1990 | US4925860 Anticonvulsants |
05/15/1990 | US4925854 Benzimidazole derivatives |
05/15/1990 | US4925793 Human immune interferon |
05/15/1990 | US4925648 Two specific antibodies(or fragments) bound to imaging agents |
05/15/1990 | CA1269109A2 Erythro diols |
05/15/1990 | CA1269107A1 Process for preparing new hydroxy alkoxy 4- phenylpropylindole derivatives and the salts thereof |
05/15/1990 | CA1269103A1 Pyrido[1,2-a]pyrimidine derivatives |
05/14/1990 | CA2002931A1 Pyrazolopyrimidine type mevalonolactones |
05/14/1990 | CA2002715A1 Compositions for topical treatment of skin diseases |
05/11/1990 | CA2002609A1 Binding proteins for insulin-like growth factors |
05/10/1990 | CA2441636A1 Natural killer stimulatory factor |
05/10/1990 | CA2002637A1 Use of ethylenediaminetetraacetic acid as inhibitor of calcium/calmodulin-dependent protein kinase ii or of protein kinase c |
05/09/1990 | EP0367601A1 N-(N-succinyl-l-leucyl) agmatine, related compounds and use in pharmacology |
05/09/1990 | EP0367554A2 Insulin binders and inhibitors of insulin binding |
05/09/1990 | EP0367514A2 Human leukocyte elastase inhibitors and methods for producing and using same |
05/09/1990 | EP0367509A2 Formulations |
05/09/1990 | EP0367484A1 Carboxylic acid derivates |
05/09/1990 | EP0367447A1 Human epithelial transforming growth factor |
05/09/1990 | EP0367223A2 Chelants possessing ortho ligating functionality and complexes thereof |
05/09/1990 | EP0367205A1 2-Aminocarboxylic acids and their derivatives, methods for their preparation and their use as pharmaceutical compositions |
05/09/1990 | EP0367130A2 Pyrrolidine derivatives |
05/09/1990 | EP0366816A1 Recombinant platelet-derived growth factor A-chain derived from endothelial cells |
05/09/1990 | EP0366728A1 Polypeptides with fibronectin activity. |
05/09/1990 | EP0366669A1 Malic acid derivative containing renin inhibiting peptides |
05/09/1990 | CN1041940A Piperidinyl benzimidazoles |
05/09/1990 | CA2002413A1 Treatment of myelosuppression associated with acquired immune deficiency |
05/08/1990 | US4923888 Antiulcer agents |
05/08/1990 | US4923882 Novel amine derivatives, salts thereof and an anti-ulcer agent containing the same |
05/08/1990 | US4923881 Quinolyl methoxy compounds, processes for preparation thereof and pharmaceutical composition comprising the same |
05/08/1990 | US4923875 Method for treatment of mast cell-mediated dermatologic disorders |
05/08/1990 | US4923697 Antioxidant compositions and methods |
05/08/1990 | CA1268772A2 (4-phenyl-1,3-dioxan-cis-5-yl)acetaldehyde derivatives |
05/08/1990 | CA1268771A2 5-allyl-1,3-dioxane derivatives |
05/08/1990 | CA1268769A1 Thiazole sulfides and their use as immunomodulators |
05/08/1990 | CA1268764A1 Dihydro-2,3-benzofuran derivatives, process for preparation thereof, and pharmaceuticals compositions containing same |
05/07/1990 | CA2002261A1 High molecular weight human angiogenic factors |
05/03/1990 | WO1990004592A1 Novel s-timolol derivative and process for its preparation |
05/03/1990 | WO1990004409A1 Human leukocyte elastase inhibitors and methods of producing and using same |
05/03/1990 | WO1990004403A1 Treatment of hypertension |
05/03/1990 | WO1990004402A1 Treatment of osteoporosis |
05/03/1990 | WO1990004397A1 Preparation for transdermal application containing gestodene |
05/03/1990 | WO1990004390A1 Composition for inhibiting transmission of aids |
05/03/1990 | WO1990004387A2 Compositions for treating tobacco withdrawal symptoms |
05/03/1990 | CA2002140A1 N-(n-succinyl-l-leucyl) agmatine, related compounds and use in pharmacology |
05/02/1990 | EP0366469A2 Phosphorus containing enzyme inhibitors |
05/02/1990 | EP0366216A1 (1S,2S,3R,5R)-2-[(3S)-2-halogen-3-hydroxy-1-alken(inyl)]3-trialkylsilyloxy-7,7-(2,2-dimethyl-trimethyl-enoxy)-bicyclo[3.3.0]octane compounds, and process for their preparation |
05/02/1990 | EP0366189A2 Novel antimicrobial lactam-quinolones |
05/02/1990 | EP0366144A1 3beta,7beta-hydroxy-substituted steroids and related steroidal compounds |
05/02/1990 | EP0366066A1 Compounds and formulations for use in methods for the treatment and prophylaxis of pneumocystis cariniipneumonia and other diseases |
05/02/1990 | EP0365992A1 Heterocyclic peptide renin inhibitors |
05/02/1990 | EP0365863A2 Novel quinolyloxazole-2-ones useful as proteinkinase C inhibitors |
05/02/1990 | EP0197149B1 Method of obtaining human leukocytic interferon |
05/02/1990 | CN1041695A Method for preparing pharmaceutical curative for veterinary and human medicine, with antiviral and antitumoral effect, including pharmaceutical form of application and said curative |
05/01/1990 | US4921868 Carbamate derivatives of the oxime of 1,2,5,6-tetrahydropyridin-3-carboxaldehyde, their use as medicaments and compositions containing them |
05/01/1990 | US4921865 Aminoacylates of glycerol acetal |
05/01/1990 | US4921855 New Histidyl amino acid derivatives, and pharmaceutical composition comprising the same |
05/01/1990 | US4921840 Method for the preparation of low molecular weight alkali metal huminates |
05/01/1990 | US4921697 IFN-gamma as an active substance for inhibiting and preventing degradation processes in bone |
05/01/1990 | CA2001906A1 Formulations |
04/28/1990 | CA2001695A1 Phosphorous containing enzyme inhibitors |
04/27/1990 | CA2001629A1 Human leukocyte elastase inhibitors and methods of producing and using same |
04/25/1990 | EP0365421A1 Specific ligands for estrogenic and progestagenic steroidal hormone receptors, their use and synthesis intermediates |
04/25/1990 | EP0365183A1 Biologically active compounds |
04/25/1990 | EP0365149A2 Leukotriene antagonist prodrugs |
04/25/1990 | EP0365089A2 2-Aryl-5(3-methoxy-5-(hydroxypropylsulfonyl)-4-propoxyphenyl) tetrahydrothiophen and analogs |
04/25/1990 | EP0364804A1 Non-peptide renin inhibitors |